Brief: PMV Pharmaceuticals Q1 EPS USD -0.34
12/05/2026 13:00
May 12 (Reuters) - PMV Pharmaceuticals Q1 operating expenses USD 19.019 million. Q1 net income USD -18.038 million Q1 operating income USD -19.019 million
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics